axPsA and AS adult pts exhibit different genetic risk factors & serum IL-17 levels. GUS demonstrated significant pharmacodynamic effects and clinical improvement in axPsA and non-axPsA pts. Abs 1038 #ACR22 @RheumNow
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Ankylosing Spondylitis - ACR Meeting Abstracts
